Please complete the CAPTCHA to continue
@moleculin.com
✓
3 phones found area 602 and 609
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Robert Shepard is listed as Consultant in Oncology, Hematology, and Immunology Drug Development; CMO, Moleculin Biotech - Part-time at Moleculin, LLC, based in United States, United States, United States. AeroLeads shows a work email signal at moleculin.com, phone signal with area code 602, 609, and a matched LinkedIn profile for Robert Shepard.
Robert Shepard previously worked as Principal Consultant at Hematology/Oncology Drug Development And Clinical Trials Consulting and CMO - Part-time at Moleculin, Llc. Robert Shepard holds Postdoctoral Fellowship, Pharmacology And Molecular Genetics from Harvard Medical School.
This section adds company-level context without repeating Robert Shepard's masked contact details.
AeroLeads found 1 current-domain work email signal for Robert Shepard. Compare company email patterns before reaching out.
My career has evolved from basic science laboratory research in the immunology and molecular genetics of cancer to translational and clinical cancer research and specifically developmental therapeutics. I have designed, written, and implemented numerous clinical trials including ones for most of the hematological and solid malignancies. I recently ran a phase II trial with a biologic for carcinoids, an immune therapy with genetic engineering for melanomas,a phase I/II with a new generation anthracycline for acute leukemias,a global phase III registration trial in GIST as well as many others before that over 25 years as a lead investigator and PI. I am also looking for funding for a phase II registration trial for second line therapy in AML with nanomolecular liposomal annamycin that had very promising results in my completed phase I/II trial. I am now in full-time consulting in Oncology and Hematology Clinical Trials and Drug Development, CMO of AnnaMed and Callisto Pharmaceuticals, and an External Reviewer on the Millennium Clinical Research Board. My background also includes experience as a Medical Officer in CBER.Specialties: Designing, writing, implementing, and accelerating clinical trials in oncology, hematology, and immunology and presenting to the FDA in pre-IND, pre-NDA, and end-of-phase 2 meetings.
Listed skills include Oncology, Clinical Trials, Pharmaceutical Industry, Drug Development, and 34 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
I was the global oncology lead for 3 clinical trials, 2 of which were phase III registration trials, 1 for a biotech and the other 2 for a Big Pharma company. I also wrote, implemented, and successfully ran multiple clinical trials of all phases as a consulting CMO.
Consultant in oncology clinical trials and drug development with special expertise in designing, implementing, accelerating enrollment, and successfully completing all phases of clinical trials, both US and global.
Cambridge, Cambridgeshire, GB
I was a full-time contractor with AstraZeneca from February 2014 to February 2017 for the maximum of 3 years. From February 2014 to July 2015, I was in Global Medicines Development as the Senior Global Medical Lead helping to run 2 global clinical trials simultaneously. One was a phase III registration trial for breast cancer and the second a phase I then.
I wrote a phase 2 registration trial for nanomolecular liposomal annamycin for second line treatment of adult AML, and am now involved in fund raising to implement it. I had run the phase 1b/2a trial as CMO of Callisto Pharmaceuticals.
BD for new sponsors in Oncology, Hematology, and Immunology. Medical monitoring, and writing, implementing,running, and accelerating enrollment in clinical trials from phase I to III..
Cambridge, MA, US
I and one other physician are the first External Reviewers for the Millennium Pharmaceuticals Clinical Research Board which reviews and gives recommendations on protocols and clinical trials.
I went from a full time consultant to an Executive Director position right before Kendle ceased to exist in the same role as when I was a consultant.
My job was to strategically align oncology, bring more business, and supervise and accelerate enrollment in oncology, hematology, and immunology clinical trials.
Cambridge, Massachusetts, US
Consultant and medical monitor for global phase III registration trial
Cambridge, Massachusetts, US
I helped run their global phase 3 registration trial for Hsp-90 in GIST, working closely with Quintiles.
US
Designed, wrote, and implemented acute leukemia, solid tumor clinical trials and a Transgenic Lymphocyte Immunotherapy (TLI) clinical trial with genetic engineering and insertion of an anti-telomerase gene - subjects are injected with autologous B lymphocytes that have been programmed ex vivo, by using plasmid DNA, to express immunoglobulin molecules.
US
Chief Medical Officer - designed, wrote, implemented, and completed a phase II trial with an investigational biologic, Atiprimod, for carcinoids and a phase I/II with the investigational nanomolecular liposomal anthracycline for adult ALL and pediatric AML and ALL.
Raleigh, North Carolina, US
Strategic consulting on drug development and clinical research in oncology, hematology, and immunology
I set up and implemented a phase 2 clinical trial in immunotherapy and met with the FDA in an EOP2 meeting.
Cambridge, Cambridgeshire, GB
Oncology and Hematology clinical research and drug development
Charlottesville, Virginia, US
PI for ECOG; Director of GI and GU Oncology and Developmental Therapeutics; Co-Chair of ECOG Myeloma Committee; Study chair or co-chair of ECOG clinical trials in myeloma, breast cancer, and pancreatic cancer studies; PI for numerous clinical trials
Quick answers generated from the profile data available on this page.
Robert Shepard works for Moleculin, LLC.
Robert Shepard is listed as Consultant in Oncology, Hematology, and Immunology Drug Development; CMO, Moleculin Biotech - Part-time at Moleculin, LLC.
AeroLeads has found 1 work email signal at @moleculin.com for Robert Shepard at Moleculin, LLC.
AeroLeads has found 3 phone signal(s) with area code 602, 609 for Robert Shepard at Moleculin, LLC.
Robert Shepard is based in United States, United States, United States while working with Moleculin, LLC.
Robert Shepard has worked for Hematology/Oncology Drug Development And Clinical Trials Consulting, Moleculin, Llc, Dr. Robert Shepard, Astrazeneca, and Annamed.
You can use AeroLeads to view verified contact signals for Robert Shepard at Moleculin, LLC, including work email, phone, and LinkedIn data when available.
Robert Shepard holds Postdoctoral Fellowship, Pharmacology And Molecular Genetics from Harvard Medical School.
Robert Shepard is listed with skills including Oncology, Clinical Trials, Pharmaceutical Industry, Drug Development, Clinical Research, Immunology, Cancer, and Clinical Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts